Savarese G, Lund LH (2017) Global public health burden of heart failure. Card Fail Rev 03:7–11

Article  Google Scholar 

Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200

PubMed  Article  Google Scholar 

Lund LH, Claggett B, Liu J et al (2018) Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. Eur J Heart Fail 20:1230–1239

CAS  PubMed  Article  Google Scholar 

Chioncel O, Lainscak M, Seferovic PM et al (2017) Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 19:1574–1585

CAS  PubMed  Article  Google Scholar 

Koh AS, Tay WT, Teng THK et al (2017) A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail 19:1624–1634

PubMed  Article  Google Scholar 

Uijl A, Lund LH, Vaartjes I et al (2020) A registry-based algorithm to predict ejection fraction in patients with heart failure. ESC Hear Fail 7:2388–2397

Article  Google Scholar 

Tsuji K, Sakata Y, Nochioka K et al (2017) Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study. Eur J Heart Fail 19:1258–1269

PubMed  Article  Google Scholar 

Rickenbacher P, Kaufmann BA, Maeder MT et al (2017) Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Eur J Heart Fail 19:1586–1596

CAS  PubMed  Article  Google Scholar 

Cheng RK, Cox M, Neely ML et al (2014) Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J 168:721–730

PubMed  Article  Google Scholar 

Ibrahim NE, Song Y, Cannon CP et al (2019) Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®. ESC Hear Fail 6:784–792

Article  Google Scholar 

Fonarow GC, Stough WG, Abraham WT et al (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure. J Am Coll Cardiol 50:768–777

PubMed  Article  Google Scholar 

Solomon SD, Claggett B, Lewis EF et al (2016) Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J 37:455–462

CAS  PubMed  Article  Google Scholar 

Cleland JGF, Bunting KV, Flather MD et al (2018) Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J 39:26–35

CAS  PubMed  Article  Google Scholar 

Lam CSP, Voors AA, Piotr P, McMurray JJV, Solomon SD (2020) Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction. Eur Heart J 41:2353–2355

PubMed  Article  Google Scholar 

Bozkurt B, Coats AJ, Tsutsui H et al (2021) universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail 27:387–413

Article  Google Scholar 

McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726

CAS  PubMed  Article  Google Scholar 

Branca L, Sbolli M, Metra M, Fudim M (2020) Heart failure with mid-range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines. ESC Hear Fail 7:381–399. https://doi.org/10.1002/ehf2.12586

Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF/AHA guideline for the management of heart failure. Circulation 128:e240-327

PubMed  Google Scholar 

Cui X, Thunström E, Dahlström U, Zhou J, Ge J, Fu M (2020) Trends in cause‐specific readmissions in heart failure with preserved vs. reduced and mid‐range ejection fraction. ESC Hear Fail 7:2894–903

Voigt JU, Cvijic M (2019) 2- and 3-dimensional myocardial strain in cardiac health and disease. JACC Cardiovasc Imaging 12:1849–1863

PubMed  Article  Google Scholar 

Baron T, Berglund L, Hedin E-M, Flachskampf FA (2019) Test–retest reliability of new and conventional echocardiographic parameters of left ventricular systolic function. Clin Res Cardiol 108:355–365

PubMed  Article  Google Scholar 

Otterstad JE, Froeland G, St. John Sutton M, Holme I (1997) Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 18:507–13

Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popović ZB, Marwick TH (2013) Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes. J Am Coll Cardiol 61:77–84

PubMed  Article  Google Scholar 

Webb J, Draper J, S. Carr-White G (2018) What proportion of patients with heart failure and left ventricular ejection fraction 40% to 49% fulfill the criteria for heart failure with mid-range ejection fraction? Am J Cardiol 122:2166–7

Rastogi A, Novak E, Platts AE, Mann DL (2017) Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction. Eur J Heart Fail 19:1597–1605

CAS  PubMed  Article  Google Scholar 

Savarese G, Vedin O, D’Amario D et al (2019) Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure. JACC Hear Fail 7:306–317

Article  Google Scholar 

Lupón J, Gavidia-Bovadilla G, Ferrer E et al (2018) Dynamic trajectories of left ventricular ejection fraction in heart failure. J Am Coll Cardiol 72:591–601

PubMed  Article  Google Scholar 

Halliday BP, Wassall R, Lota AS et al (2019) Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet 393:61–73

PubMed  PubMed Central  Article  Google Scholar 

Wilcox JE, Fang JC, Margulies KB, Mann DL (2020) Heart failure with recovered left ventricular ejection fraction: JACC scientific expert panel. J Am Coll Cardiol 76:719–734

PubMed  Article  Google Scholar 

Park JJ, Mebazaa A, Hwang I, Park J, Park J, Cho G (2020) Phenotyping heart failure according to the longitudinal ejection fraction change: myocardial strain, predictors, and outcomes. J Am Heart Assoc 9:e015009

PubMed  PubMed Central  Article  Google Scholar 

Triposkiadis F, Butler J, Abboud FM et al (2019) The continuous heart failure spectrum: moving beyond an ejection fraction classification. Eur Heart J 40:2155–2163

PubMed  PubMed Central  Article  Google Scholar 

Tromp J, Westenbrink BD, Ouwerkerk W et al (2018) Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 72:1081–1090

CAS  PubMed  Article  Google Scholar 

Tromp J, Khan MAF, Mentz RJ et al (2017) Biomarker profiles of acute heart failure patients with a mid-range ejection fraction. JACC Hear Fail 5:507–517

Article  Google Scholar 

Gohar A, Chong JPC, Liew OW et al (2017) The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction. Eur J Heart Fail 19:1638–47

Vergaro G, Aimo A, Prontera C et al (2019) Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction. Int J Cardiol 296:91–97

PubMed  Article  Google Scholar 

Jimenez-Marrero S, Moliner P, Rodríguez-Costoya I et al (2020) Sympathetic activation and outcomes in chronic heart failure: does the neurohormonal hypothesis apply to mid-range and preserved ejection fraction patients? Eur J Intern Med 81:60–66

CAS  PubMed  Article  Google Scholar 

Doeblin P, Hashemi D, Tanacli R et al (2019) CMR tissue characterization in patients with HFmrEF. J Clin Med 8:1877

CAS  PubMed Central  Article  Google Scholar 

Adamo L, Yu J, Rocha-Resende C, Javaheri A, Head RD, Mann DL (2020) Proteomic signatures of heart failure in relation to left ventricular ejection fraction. J Am Coll Cardiol 76:1982–1994

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gevaert AB, Tibebu S, Mamas MA et al (2021) Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes. ESC Hear Fail 8:2741–2754

Article  Google Scholar 

Khan MS, Samman Tahhan A, Vaduganathan M et al (2020) Trends in prevalence of comorbidities in heart failure clinical trials. Eur J Heart Fail 22:1032–1042

PubMed  Article  Google Scholar 

Vedin O, Lam CSP, Koh AS et al (2017) Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction. Circ Hear Fail 10:e003875

Article  Google Scholar 

Savarese G, Settergren C, Schrage B et al (2020) Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: a blueprint for clinical trial design. Int J Cardiol 313:76–82

PubMed  Article  Google Scholar 

Streng KW, Nauta JF, Hillege HL et al (2018) Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. Int J Cardiol 271:132–139

PubMed  Article  Google Scholar 

Shah KS, Xu H, Matsouaka RA et al (2017) Heart failure with preserved, borderline, and reduced ejection fraction. J Am Coll Cardiol 70:2476–2486

PubMed  Article  Google Scholar 

Vergaro G, Ghionzoli N, Innocenti L et al (2019) Noncardiac versus cardiac mortality in heart failure with preserved, midrange, and reduced ejection fraction. J Am Heart Assoc 8:e013441

PubMed  PubMed Central  Article  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145:e895–e1032

PubMed  Google Scholar 

Lam CSP, Solomon SD (2014) The middle child in heart failure: heart failure with mid-range ejection fraction (40–50%). Eur J Heart Fail 16:1049–1055